According to Nectar Lifesciences 's latest financial reports the company's total assets are $0.25 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-03-31 | $0.26 B | -15.43% |
2022-03-31 | $0.31 B | -3.03% |
2021-03-31 | $0.32 B | -6.9% |
2020-03-31 | $0.34 B | -10.36% |
2019-03-31 | $0.38 B | -6.88% |
2018-03-31 | $0.41 B | 5.03% |
2017-03-31 | $0.39 B | 3.42% |
2016-03-31 | $0.38 B | -0.91% |
2015-03-31 | $0.38 B | -2.85% |
2014-03-31 | $0.40 B | -4.51% |
2013-03-31 | $0.41 B | 0.49% |
2012-03-31 | $0.41 B | 2.61% |
2011-03-31 | $0.40 B | 22.95% |
2010-03-31 | $0.33 B | 30.54% |
2009-03-31 | $0.25 B | 6.46% |
2008-03-31 | $0.23 B | 32.11% |
2007-03-31 | $0.17 B | 75.24% |
2006-03-31 | $0.10 B |